A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer

A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer

Abstract Background Bladder cancer (BLCA) represents a highly heterogeneous disease characterized by distinct histological, molecular, and clinical features, whose tumorigenesis and progression require aberrant metabolic reprogramming of tumor cells. However, current studies have not expounded syste...

Full description

Bibliographic Details
Main Authors: Yun Cai, Yifei Cheng, Ziyu Wang, Lu Li, Zhengtao Qian, Wei Xia, Weiwei Yu
Format: Article
Language:English
Published: BMC 2023-08-01
Series:BMC Cancer
Subjects:
Bladder cancer
Metabolic heterogeneity
Tumor microenvironment
S100A7
Online Access:https://doi.org/10.1186/s12885-023-11182-w

Similar Items

Similar Items